Correlation Between CytomX Therapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Neoleukin Therapeutics.
Diversification Opportunities for CytomX Therapeutics and Neoleukin Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CytomX and Neoleukin is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Neoleukin Therapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.78 times less return on investment than Neoleukin Therapeutics. In addition to that, CytomX Therapeutics is 2.2 times more volatile than Neoleukin Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 47.00 in Neoleukin Therapeutics on August 23, 2024 and sell it today you would earn a total of 22.00 from holding Neoleukin Therapeutics or generate 46.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 32.26% |
| Values | Daily Returns |
CytomX Therapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
CytomX Therapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite CytomX Therapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| CytomX Therapeutics vs. Kiora Pharmaceuticals | CytomX Therapeutics vs. ZyVersa Therapeutics | CytomX Therapeutics vs. Sonnet Biotherapeutics Holdings | CytomX Therapeutics vs. Zura Bio Limited |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |